Skip to main navigation Skip to search Skip to main content

Safety and Pharmacokinetics of Single, Escalating Oral Doses of Amdoxovir (DAPD) in HIV-1 Infected or Exposed Pediatric Patients

Project: Research

Project Details

StatusFinished
Effective start/end date11/1/01 → 11/10/04

Funding

  • Triangle Pharmaceuticals Incorporated: $35,713.13